After a sell-off at the end of 2024 following Donald Trump’s re-election, the biopharma sector seems to be bouncing back.
Share this post
Can a Sector Bounce-back Boost These 3…
Share this post
After a sell-off at the end of 2024 following Donald Trump’s re-election, the biopharma sector seems to be bouncing back.